{"component": "definition", "props": {"groups": [{"samples": [{"hash": "1DcXDOYaMK9", "uri": "/contracts/1DcXDOYaMK9#licensing-transaction", "label": "Collaboration Agreement (Macrogenics Inc)", "score": 24.7563312799, "published": true}, {"hash": "kDZYo4wEeh4", "uri": "/contracts/kDZYo4wEeh4#licensing-transaction", "label": "Collaboration Agreement (Macrogenics Inc)", "score": 24.6741957563, "published": true}, {"hash": "1NLdooRbXR", "uri": "/contracts/1NLdooRbXR#licensing-transaction", "label": "Collaboration Agreement (Macrogenics Inc)", "score": 24.5838466804, "published": true}], "size": 6, "snippet_links": [], "snippet": "has the meaning set forth in Section 12.3(d)(ii)(C).", "hash": "46017575e952eeb33ea0d37bb9bd01b2", "id": 1}, {"samples": [{"hash": "6gEDYiErX9F", "uri": "/contracts/6gEDYiErX9F#licensing-transaction", "label": "Development Funding Agreement (Apellis Pharmaceuticals, Inc.)", "score": 30.3442847365, "published": true}, {"hash": "54cYGSdyNRY", "uri": "https://investors.apellis.com/static-files/3e75570f-33e0-4dc2-8157-c9bb84b1fb48", "label": "investors.apellis.com", "score": 9.9979466119, "published": false}], "size": 3, "snippet_links": [{"key": "license-to", "type": "clause", "offset": [12, 22]}, {"key": "intellectual-property", "type": "clause", "offset": [66, 87]}, {"key": "transfer-to-a-third-party", "type": "clause", "offset": [231, 256]}, {"key": "assignment-of", "type": "clause", "offset": [334, 347]}], "snippet": "means (a) a license to a Third Party of any of the APL Restricted Intellectual Property in the US or Europe, (b) a sublicense to a Third Party of any of the APL Restricted Intellectual Property in the US or Europe or (c) a sale or transfer to a Third Party of any of the APL Restricted Intellectual Property in the US or Europe or an assignment of either of the Penn Licenses to a Third Party.", "hash": "361d12fee0e859ca2cbe9878c8e573d1", "id": 2}, {"samples": [{"hash": "e9ylj4ihXcA", "uri": "/contracts/e9ylj4ihXcA#licensing-transaction", "label": "Loan Agreement (Tenby Pharma Inc)", "score": 21.0, "published": true}], "size": 2, "snippet_links": [{"key": "by-borrower", "type": "clause", "offset": [30, 41]}, {"key": "board-of-directors", "type": "clause", "offset": [44, 62]}, {"key": "affirmative-vote", "type": "definition", "offset": [78, 94]}, {"key": "by-lender", "type": "definition", "offset": [131, 140]}], "snippet": "means a transaction, approved by Borrower\u2019s Board of Directors (including the affirmative vote of at least one director designated by Lender), by which Borrower licenses, controls or otherwise gains rights to a Product.", "hash": "b5a1d43830d7f80e11634d53171e4d98", "id": 3}, {"samples": [{"hash": "9khOqwdyyoc", "uri": "/contracts/9khOqwdyyoc#licensing-transaction", "label": "Intercreditor Deed (Innocoll Holdings PLC)", "score": 25.3538672142, "published": true}], "size": 1, "snippet_links": [{"key": "pursuant-to", "type": "definition", "offset": [22, 33]}, {"key": "single-cash-payment", "type": "definition", "offset": [78, 97]}, {"key": "the-transaction", "type": "clause", "offset": [114, 129]}, {"key": "in-consideration-for", "type": "clause", "offset": [130, 150]}, {"key": "licence-of-intellectual-property-rights", "type": "clause", "offset": [162, 201]}, {"key": "a-person", "type": "clause", "offset": [205, 213]}, {"key": "of-the-borrower", "type": "clause", "offset": [240, 255]}], "snippet": "means any transaction pursuant to which the Borrower (as licensor) receives a single cash payment at the start of the transaction in consideration for granting a licence of intellectual property rights to a person which is not a Subsidiary of the Borrower (as licensee)", "hash": "75c4c6c4f93022118b183512860b3d04", "id": 4}, {"samples": [{"hash": "jjb6OKIEbwO", "uri": "/contracts/jjb6OKIEbwO#licensing-transaction", "label": "Development Funding Agreement (Stealth BioTherapeutics Corp)", "score": 31.841889117, "published": true}], "size": 1, "snippet_links": [{"key": "intellectual-property", "type": "clause", "offset": [90, 111]}, {"key": "with-respect-to", "type": "clause", "offset": [112, 127]}, {"key": "the-product", "type": "clause", "offset": [128, 139]}, {"key": "the-designated", "type": "definition", "offset": [144, 158]}, {"key": "in-the-united-states", "type": "clause", "offset": [171, 191]}, {"key": "transfer-to-a-third-party", "type": "clause", "offset": [210, 235]}, {"key": "each-case", "type": "definition", "offset": [284, 293]}, {"key": "assignment-of-this-agreement", "type": "clause", "offset": [338, 366]}, {"key": "pursuant-to-section", "type": "clause", "offset": [367, 386]}, {"key": "in-connection-with", "type": "clause", "offset": [392, 410]}, {"key": "sale-or-other-transfer", "type": "clause", "offset": [415, 437]}, {"key": "all-or-substantially-all", "type": "clause", "offset": [441, 465]}, {"key": "for-the-avoidance-of-doubt", "type": "clause", "offset": [525, 551]}, {"key": "the-license", "type": "definition", "offset": [694, 705]}, {"key": "transfer-of-the", "type": "clause", "offset": [709, 724]}], "snippet": "means: (a) a license or sublicense from Stealth to a Third Party under any of the Stealth Intellectual Property with respect to the Product for the Designated Indications in the United States; or (b) a sale or transfer to a Third Party of any of the Stealth Intellectual Property, in each case, other than in conjunction with a permitted assignment of this Agreement pursuant to Section 11.5 in connection with the sale or other transfer of all or substantially all of its business or assets to which this Agreement relates. For the avoidance of doubt, a royalty finance or similar agreement with respect to the Product for the Designated Indications in the United States that does not involve the license or transfer of the Stealth Intellectual Property is not a Licensing Transaction.", "hash": "3f0ca43f8384cd60ad29266babb0d9c5", "id": 5}, {"samples": [{"hash": "ckyIqdshm0T", "uri": "/contracts/ckyIqdshm0T#licensing-transaction", "label": "Consolidated Loan Agreement (Liminal BioSciences Inc.)", "score": 28.87816564, "published": true}], "size": 1, "snippet_links": [{"key": "rights-of-the-borrower", "type": "clause", "offset": [49, 71]}], "snippet": "means the out-licensing of the commercialization rights of the Borrower for its plasma-derived therapeutics designated as RYPLAZIM\u2122 (plasminogen).", "hash": "0c857c829b99694a9e1ce29e82dbeeed", "id": 6}, {"samples": [{"hash": "6mPY5MILh0e", "uri": "/contracts/6mPY5MILh0e#licensing-transaction", "label": "Credit Agreement (Cluett American Corp)", "score": 18.0, "published": true}], "size": 1, "snippet_links": [{"key": "the-sale", "type": "clause", "offset": [0, 8]}, {"key": "the-intellectual-property", "type": "definition", "offset": [30, 55]}, {"key": "royalty-payments", "type": "clause", "offset": [82, 98]}], "snippet": "the sale or securitization of the intellectual property of the Shirt Group or the royalty payments related thereto.", "hash": "13cf122fa4fb0369c995881e2c48c87c", "id": 7}, {"samples": [{"hash": "f8frN4GNwnO", "uri": "/contracts/f8frN4GNwnO#licensing-transaction", "label": "Co Development Agreement (PhaseBio Pharmaceuticals Inc)", "score": 31.2422997947, "published": true}], "size": 1, "snippet_links": [{"key": "intellectual-property", "type": "clause", "offset": [72, 93]}, {"key": "to-commercialize", "type": "definition", "offset": [94, 110]}, {"key": "the-product", "type": "clause", "offset": [111, 122]}, {"key": "designated-european-countries", "type": "definition", "offset": [134, 163]}, {"key": "asian-countries", "type": "definition", "offset": [179, 194]}, {"key": "in-the-case", "type": "clause", "offset": [208, 219]}, {"key": "on-behalf-of", "type": "clause", "offset": [316, 328]}, {"key": "engage-in-any", "type": "definition", "offset": [388, 401]}, {"key": "other-commercialization-activities", "type": "clause", "offset": [402, 436]}, {"key": "with-respect-to", "type": "clause", "offset": [437, 452]}, {"key": "transfer-to-a-third-party", "type": "clause", "offset": [484, 509]}, {"key": "each-case", "type": "definition", "offset": [553, 562]}, {"key": "assignment-of-this-agreement", "type": "clause", "offset": [607, 635]}, {"key": "section-156", "type": "clause", "offset": [648, 660]}, {"key": "in-connection-with", "type": "clause", "offset": [661, 679]}, {"key": "transfer-of", "type": "definition", "offset": [698, 709]}, {"key": "all-or-substantially-all", "type": "clause", "offset": [710, 734]}, {"key": "for-clarity", "type": "clause", "offset": [794, 805]}, {"key": "assignment-of-the", "type": "clause", "offset": [810, 827]}, {"key": "license-to", "type": "clause", "offset": [831, 841]}, {"key": "assignment-by", "type": "clause", "offset": [888, 901]}], "snippet": "means: (a) a license or sublicense to a Third Party under any of the PB Intellectual Property to Commercialize the Product in the US, Designated European Countries, or Designated Asian Countries (other than, in the case of a Third Party CMO, a license or sublicense to commercially manufacture PB2452 or the Product on behalf of PB or its Affiliates, without any license or sublicense to engage in any other Commercialization activities with respect to the Product); or (b) a sale or transfer to a Third Party of any of the PB Intellectual Property, in each case, other than in conjunction with a permitted assignment of this Agreement pursuant to Section 15.6 in connection with the sale or other transfer of all or substantially all of its business or assets to which this Agreement relates. For clarity, an assignment of the AZ License to a Third Party in conjunction with a permitted assignment by PB of this Agreement pursuant to Section 15.6 in connection with the sale or other transfer of all or substantially all of its business or assets to which this Agreement relates shall not be deemed a Licensing Transaction.", "hash": "c43bde2967ce56954b7417c71480302f", "id": 8}, {"samples": [{"hash": "lCG0uTZh67f", "uri": "/contracts/lCG0uTZh67f#licensing-transaction", "label": "License and Research and Development Agreement (Texas Biotechnology Corp /De/)", "score": 18.0, "published": true}], "size": 1, "snippet_links": [{"key": "agreement-or", "type": "definition", "offset": [10, 22]}, {"key": "pursuant-to", "type": "definition", "offset": [47, 58]}, {"key": "a-third-party", "type": "clause", "offset": [98, 111]}, {"key": "rights-of", "type": "definition", "offset": [128, 137]}, {"key": "subject-technology", "type": "definition", "offset": [154, 172]}, {"key": "subject-of-this-agreement", "type": "clause", "offset": [207, 232]}, {"key": "including-without-limitation", "type": "clause", "offset": [233, 261]}, {"key": "rights-to-use", "type": "clause", "offset": [266, 279]}, {"key": "field-of-use", "type": "definition", "offset": [320, 332]}], "snippet": "means any agreement or arrangement of any type pursuant to which Revotar licenses or transfers to a Third Party any interest or rights of any kind to any Subject Technology, Compound or Product which is the subject of this Agreement including without limitation the rights to use and sell any Compound or Product in the Field of Use.", "hash": "c441e01f5bd61877f0498228d0f8be31", "id": 9}, {"samples": [{"hash": "hrlIrPruoqq", "uri": "http://pdf.secdatabase.com/2402/0001564590-20-050587.pdf", "label": "pdf.secdatabase.com", "score": 11.4257357974, "published": false}], "size": 1, "snippet_links": [], "snippet": "means: (a) a license or sublicense from Stealth to a Third", "hash": "84516d93a5888e3be69b764a0afecfea", "id": 10}], "next_curs": "CmISXGoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj4LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIebGljZW5zaW5nLXRyYW5zYWN0aW9uIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "Licensing Transaction", "size": 21, "snippet": "has the meaning set forth in Section 12.3(d)(ii)(C).", "id": "licensing-transaction", "examples": ["Without the consent of the Representative, the Company shall not amend, modify, waive or terminate any provision of any of the lock-up agreements entered into in connection with the <strong>Licensing Transaction</strong> except to extend the term of the lock-up period and shall enforce the provisions of the lock-up agreements in accordance with their terms.", "The termination of the <strong>Licensing Transaction</strong> will be effective as of the date of the court approval.", "For the avoidance of doubt, this Section 2.02(c) shall not apply to any Disposition consisting of a Permitted <strong>Licensing Transaction</strong>.", "Any portion of the Intellectual Property Collateral that is licensed pursuant to a Permitted <strong>Licensing Transaction</strong> shall be automatically excluded from the Negative Pledge Agreement, effective immediately prior to Borrower\u2019s entering into such Permitted <strong>Licensing Transaction</strong>.", "For clarity, there shall be no amounts payable under this Section 6.6.2 in the event of an Omav <strong>Licensing Transaction</strong> consummated on or after January 1, 2028.", "The Borrower hereby acknowledges and confirms that it will use its reasonable best efforts to complete the PBL Sale by the Outside Date (as defined in the Share Purchase Agreement) and the <strong>Licensing Transaction</strong> by [REDACTED \u2013 SENSITIVE COMMERCIAL INFORMATION].", "A (a) Withdrawal Event occurs with respect to SKYCLARYS\u2122, (b) a Material Adverse Change occurs or (c) Borrower enters into or consummates an Omav <strong>Licensing Transaction</strong> (unless the Collateral Agent has consented thereto pursuant to Section 6.1 hereof).", "In connection with any Excluded <strong>Licensing Transaction</strong> and any other licensing of Intellectual Property permitted pursuant to this Agreement, Investor shall enter into a customary non-disturbance agreement to the extent requested by Opthea, in each case reasonably satisfactory to Investor and the counterparty thereto.", "Revotar will inform TBC if it enters into negotiations with a Third Party concerning any <strong>Licensing Transaction</strong>.", "Notwithstanding any other provision of this Agreement, Borrower shall not enter into or consummate a Omav <strong>Licensing Transaction</strong> without the prior written consent of the Collateral Agent in its sole discretion."], "related": [["factoring-transaction", "Factoring Transaction", "Factoring Transaction"], ["closing-transactions", "Closing Transactions", "Closing Transactions"], ["restructuring-transaction", "Restructuring Transaction", "Restructuring Transaction"], ["financing-transaction", "Financing Transaction", "Financing Transaction"], ["financing-transactions", "Financing Transactions", "Financing Transactions"]], "related_snippets": [], "updated": "2025-07-06T21:58:41+00:00"}, "json": true, "cursor": ""}}